Nugevia MND

Nugevia MND is a dietary supplement developed by Jupiter Neurosciences, Inc. (NASDAQ: JUNS) as part of its Nugevia product line. It is formulated to support cognitive function and brain health, specifically targeting older adults seeking to maintain cognitive performance and protect against age-related decline. The product is a combination of two primary active components: JOTROL, Jupiter's proprietary resveratrol-based technology platform designed for enhanced bioavailability, and NovaSOL Curcumin, a highly bioavailable liquid curcumin formulation. Nugevia MND is intended to reduce oxidative stress and neuroinflammation, enhance synaptic plasticity, and support mitochondrial function in brain cells. Launched in Fall 2025, it is marketed as a nutraceutical supplement available through direct-to-consumer e-commerce platforms rather than a traditional pharmaceutical drug.

Brand names

Nugevia MND